140 related articles for article (PubMed ID: 1538150)
1. Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman.
Sutter RW; Patriarca PA; Suleiman AJ; Brogan S; Malankar PG; Cochi SL; Al-Ghassani AA; el-Bualy MS
J Infect Dis; 1992 Mar; 165(3):444-9. PubMed ID: 1538150
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
Strebel PM; Ion-Nedelcu N; Baughman AL; Sutter RW; Cochi SL
N Engl J Med; 1995 Feb; 332(8):500-6. PubMed ID: 7830731
[TBL] [Abstract][Full Text] [Related]
3. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
4. Outbreak of poliomyelitis due to type 3 poliovirus, northern India, 1999-2000: injections a major contributing factor.
Kohler KA; Hlady WG; Banerjee K; Sutter RW
Int J Epidemiol; 2003 Apr; 32(2):272-7. PubMed ID: 12714548
[TBL] [Abstract][Full Text] [Related]
5. Provocation paralysis.
Eggers HJ; Weyer J
Lancet; 1993 Jan; 341(8836):62. PubMed ID: 8093318
[No Abstract] [Full Text] [Related]
6. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children.
Sutter RW; Patriarca PA; Brogan S; Malankar PG; Pallansch MA; Kew OM; Bass AG; Cochi SL; Alexander JP; Hall DB
Lancet; 1991 Sep; 338(8769):715-20. PubMed ID: 1679866
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
[TBL] [Abstract][Full Text] [Related]
8. Provocation paralysis.
Wyatt HV
Lancet; 1993 Jan; 341(8836):61-2. PubMed ID: 8093316
[No Abstract] [Full Text] [Related]
9. Poliomyelitis in Oman: acute flaccid paralysis surveillance leading to early detection and rapid response to a type 3 outbreak.
Robertson SE; Suleiman AJ; Mehta FR; al-Dhahry SH; el-Bualy MS
Bull World Health Organ; 1994; 72(6):907-14. PubMed ID: 7867136
[TBL] [Abstract][Full Text] [Related]
10. Flawed immunisation policies in India led to polio paralysis.
Mudur G
BMJ; 1998 Apr; 316(7140):1264. PubMed ID: 9599049
[TBL] [Abstract][Full Text] [Related]
11. Injections and poliomyelitis: what are the risks of vaccine associated paralysis?
Wyatt HV
Dev Biol Stand; 1986; 65():123-6. PubMed ID: 3549394
[TBL] [Abstract][Full Text] [Related]
12. Unnecessary injections and paralytic poliomyelitis in India.
Wyatt HV; Mahadevan S; Srinivasan S
Trans R Soc Trop Med Hyg; 1992; 86(5):546-9. PubMed ID: 1475830
[TBL] [Abstract][Full Text] [Related]
13. Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States.
Hurwitz EL; Morgenstern H
J Manipulative Physiol Ther; 2000 Feb; 23(2):81-90. PubMed ID: 10714532
[TBL] [Abstract][Full Text] [Related]
14. Did India have the world's largest outbreak of poliomyelitis associated with injections of adjuvanted DPT?
John TJ
Indian Pediatr; 1998 Jan; 35(1):73-5. PubMed ID: 9707912
[No Abstract] [Full Text] [Related]
15. Poliomyelitis in France: epidemiology and vaccination status.
Drucker J
Pediatr Infect Dis J; 1991 Dec; 10(12):967-9. PubMed ID: 1766723
[TBL] [Abstract][Full Text] [Related]
16. Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8-12-year-old children.
Bernsen RM; de Jongste JC; Koes BW; Aardoom HA; van der Wouden JC
Vaccine; 2006 Mar; 24(12):2035-42. PubMed ID: 16368169
[TBL] [Abstract][Full Text] [Related]
17. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
[TBL] [Abstract][Full Text] [Related]
19. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.
Heininger U; Stehr K; Christenson P; Cherry JD
Clin Infect Dis; 1999 Mar; 28(3):602-4. PubMed ID: 10194085
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
